Brian Dorsey

Companies

• Silverback TherapeuticsChief operating officer Dec 9, 2022 to now¹
• Apricus BiosciencesChief Development Officer Dec 2, 2014 to Jan 3, 2018²
• Pernix Therapeutics HoldingsSVP, Research Apr 23, 2013 to Oct 10, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Silverback Therapeutics SPRY10,789 shares⁴$43.6K at $4.04Nov 13, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 13, 2025Sold 21,828 shares at $8.71 of Silverback Therapeutics⁴
• Nov 13, 2025Exercised options 21,828 shares at $0.64 of Silverback Therapeutics⁴
• Dec 12, 2024Sold 25,000 shares at $12.30 of Silverback Therapeutics⁵
• Dec 12, 2024Exercised options 25,000 shares at $0.64 of Silverback Therapeutics⁵
• Dec 11, 2024Sold 15,000 shares at $12.43 of Silverback Therapeutics⁵
• Dec 11, 2024Exercised options 15,000 shares at $0.64 of Silverback Therapeutics⁵
• Aug 20, 2024Sold 50,000 shares at $15.00 of Silverback Therapeutics⁶
• Aug 20, 2024Exercised options 50,000 shares at $0.64 of Silverback Therapeutics⁶
• Aug 13, 2024Sold 30,000 shares at $13.00 of Silverback Therapeutics⁷
• Aug 13, 2024Exercised options 30,000 shares at $0.64 of Silverback Therapeutics⁷